Filing Flows › Niagen Bioscience (NAGE) › Ingredients segment revenue
Niagen Bioscience (NAGE) Ingredients segment revenue by quarter
Niagen Bioscience's Ingredients segment revenue was $3.8M in Q3 2026 (third quarter 2026), -29% from Q2 2026. Over the last 6 quarters it ranged from $3.8M (Q3 2026) to $8.6M (Q1 2026).
| Quarter | Ingredients segment revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.8M | -29% | -47% |
| Q2 2026 | $5.4M | -37% | -29% |
| Q1 2026 | $8.6M | +19% | +5% |
| Q3 2025 | $7.2M | -6% | — |
| Q2 2025 | $7.6M | -7% | — |
| Q1 2025 | $8.2M | — | — |
Q3 2026 at a glance
Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Niagen Bioscience's Ingredients segment revenue?
Niagen Bioscience's Ingredients segment revenue was $3.8M in Q3 2026 (third quarter 2026), -29% from Q2 2026.
How has Niagen Bioscience's Ingredients segment revenue changed?
Over the last 6 quarters it ranged from $3.8M (Q3 2026) to $8.6M (Q1 2026).